Glaukos Corporation
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
See below for the Latest Glaukos Corporation News, Analysis, Profit Results, Share Price Information, and Commentary.
Micro stents, macro efficiency: How a tiny device helps preserve vision
Micro stents, macro efficiency: How a tiny device helps preserve vision
Glaukos Corporation’s iStent inject W helps preserve vision by addressing high eye pressure.
Most Read
1. Southeast Asia faces uneven urology access as demand outpaces specialists 2. Hong Kong healthcare pushes pricing clarity, trials, and biotech capacity 3. China’s healthcare index sinks 7.1% as investors pivot to tech AI 4. How the healthcare ecosystem is responding to change the trajectory of myopia 5. Seoul hospital, Harvard replace static AI testing with hospital simulatorResource Center
Read Here
Advertise
Sign Up
Event News
The facility was recognised for a programme which expanded access to specialised heart care across the country.
Commentary
How the healthcare ecosystem is responding to change the trajectory of myopia
Technology’s role in making Indian healthcare truly patient-centric